{"org_id": "T000073937", "org_name_cn": "北京赛升药业股份有限公司", "org_short_name_cn": "赛升药业", "org_name_en": "Beijing Science Sun Pharmaceutical Co.,Ltd.", "org_short_name_en": "Science Sun Pharm", "main_operation_business": "注射针剂的研发、生产及销售。", "operating_scope": "　　原料药、针剂的制造;技术开发、技术转让、技术咨询、技术服务;商业特许经营;投资、投资管理、投资咨询。", "district_encode": "110115", "org_cn_introduction": "北京赛升药业股份有限公司的主营业务为注射针剂的研发、生产及销售,主导产品为生物生化药品，涉及心脑血管类疾病、免疫性疾病(抗肿瘤)和神经系统疾病三大用药领域。公司为纤溶酶、纤溶酶注射液、注射用纤溶酶、薄芝糖肽注射液、脱氧核苷酸钠注射液5个品种的国家药品标准原研起草单位；纤溶酶注射剂、薄芝糖肽注射液、脱氧核苷酸钠注射液、100mg注射用胸腺肽为全国首家生产的药品；单唾液酸四己糖神经节苷脂钠注射液(GM-1)及薄芝糖肽注射液为国家重点新产品；纤溶酶、纤溶酶注射液、注射用纤溶酶、大规格注射用胸腺肽被评为北京市自主创新产品；免疫亲和层析规模纯化纤溶酶分离及其药学性质、药物制剂的开发研究获得北京市科学技术奖。公司及赛而生物发明专利“单唾液酸四己糖神经节苷脂的制备方法以及单唾液酸四己糖神经节苷脂钠注射液或冻干粉针”(专利号ZL200910085592.0)荣获第二十届中国专利优秀奖。", "legal_representative": "马骉", "general_manager": "马骉", "secretary": "王雪峰", "established_date": 927129600000, "reg_asset": 481666400.0, "staff_num": 621, "telephone": "86-10-67862500", "postcode": "100176", "fax": "86-10-67862501", "email": "ssyyzqb@ssyy.com.cn", "org_website": "www.ssyy.com.cn", "reg_address_cn": "北京市大兴区北京经济技术开发区兴盛街8号", "reg_address_en": "", "office_address_cn": "北京市大兴区北京经济技术开发区兴盛街8号", "office_address_en": "", "currency_encode": "019001", "currency": "CNY", "listed_date": 1435248000000, "provincial_name": "北京市", "actual_controller": "马骉 (49.51%)", "classi_name": "民营企业", "pre_name_cn": null, "chairman": "马骉", "executives_nums": 13, "actual_issue_vol": 30000000.0, "issue_price": 38.46, "actual_rc_net_amt": 1080944700.0, "pe_after_issuing": 22.99, "online_success_rate_of_issue": 0.36628586, "affiliate_industry": {"ind_code": "BK0042", "ind_name": "生物制品"}}